194 related articles for article (PubMed ID: 30439969)
1. Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.
Bouachi K; Moktefi A; Zhang SY; Oniszczuk J; Sendeyo K; Remy P; Audard V; Pawlak A; Ollero M; Sahali D
PLoS One; 2018; 13(11):e0207066. PubMed ID: 30439969
[TBL] [Abstract][Full Text] [Related]
2. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
Yuan M; Tan Y; Wang Y; Wang SX; Yu F; Zhao MH
Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145
[TBL] [Abstract][Full Text] [Related]
3. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
4. Mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis.
Wang SF; Chen YH; Chen DQ; Liu ZZ; Xu F; Zeng CH; Hu WX
Lupus; 2018 Feb; 27(2):303-311. PubMed ID: 28720048
[TBL] [Abstract][Full Text] [Related]
5. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
6. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease.
Rossini M; Cheunsuchon B; Donnert E; Ma LJ; Thomas JW; Neilson EG; Fogo AB
Kidney Int; 2005 Dec; 68(6):2621-8. PubMed ID: 16316338
[TBL] [Abstract][Full Text] [Related]
8. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
[TBL] [Abstract][Full Text] [Related]
9. No complement receptor 1 stumps on podocytes in human glomerulopathies.
Moll S; Miot S; Sadallah S; Gudat F; Mihatsch MJ; Schifferli JA
Kidney Int; 2001 Jan; 59(1):160-8. PubMed ID: 11135068
[TBL] [Abstract][Full Text] [Related]
10. Repression of CMIP transcription by WT1 is relevant to podocyte health.
Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
12. Assessment of detached podocytes in the Bowman's space as a marker of disease activity in lupus nephritis.
Moustafa FE; Soliman NA; Bakr AM; El Shwaf IM
Lupus; 2014 Feb; 23(2):146-50. PubMed ID: 24306541
[TBL] [Abstract][Full Text] [Related]
13. In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy.
Zheng L; Sinniah R; Hsu SI
Virchows Arch; 2006 Feb; 448(2):172-83. PubMed ID: 16205945
[TBL] [Abstract][Full Text] [Related]
14. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology.
Perysinaki GS; Moysiadis DK; Bertsias G; Giannopoulou I; Kyriacou K; Nakopoulou L; Boumpas DT; Daphnis E
Lupus; 2011 Jul; 20(8):781-91. PubMed ID: 21478284
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
16. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
Hill GS; Delahousse M; Nochy D; Bariéty J
Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
[TBL] [Abstract][Full Text] [Related]
17. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
18. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.
Ikuma D; Hiromura K; Kajiyama H; Suwa J; Ikeuchi H; Sakairi T; Kaneko Y; Maeshima A; Kurosawa H; Hirayama Y; Yokota K; Araki Y; Sato K; Asanuma YF; Akiyama Y; Hara M; Nojima Y; Mimura T
Lupus; 2018 Mar; 27(3):484-493. PubMed ID: 29050536
[TBL] [Abstract][Full Text] [Related]
19. Lupus Podocytopathy: An Overview.
Oliva-Damaso N; Payan J; Oliva-Damaso E; Pereda T; Bomback AS
Adv Chronic Kidney Dis; 2019 Sep; 26(5):369-375. PubMed ID: 31733721
[TBL] [Abstract][Full Text] [Related]
20. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system.
Yu F; Wu LH; Tan Y; Li LH; Wang CL; Wang WK; Qu Z; Chen MH; Gao JJ; Li ZY; Zheng X; Ao J; Zhu SN; Wang SX; Zhao MH; Zou WZ; Liu G
Kidney Int; 2010 May; 77(9):820-9. PubMed ID: 20182417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
